Brief: Cantargia Says Third Party Withdraws Appeal Related To Cantargia Patent
May 16 (Reuters) - Cantargia AB CANTA.ST :
* THIRD PARTY WITHDRAWS APPEAL RELATED TO CANTARGIA PATENT
* NOTICE OF APPEAL FILED WITH RESPECT TO ONE OF CANTARGIA'S
GRANTED EUROPEAN PATENTS, EP3020730, HAS BEEN WITHDRAWN.
* PATENT REMAINS IN FORCE WITH CLAIMS ENCOMPASSING TREATMENT
OF
SOLID TUMOURS BY ANTI-IL1RAP-TARGETING ANTIBODY
Source text for Eikon: ID:nMFN2tbfmH
Further company coverage: CANTA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Cantargia AB
See all newsBrief: Cantargia Publishes Nadunolimab CANFOUR Study Data
Brief: Cantargia Announces Outcome Of Rights Issue, Raising About SEK 75 Mln
Brief: Cantargia Carries Out Rights Issue, Enters Loan Agreement
Brief: Cantargia Q1 Operating Loss Narrows To SEK 36.9 Mln
Brief: Cantargia: Early Results From Phase 1B/2A Nadunolimab Trial In MDS And AML